Joy Aifuobhokhan

Joy Aifuobhokhan

Auto-generated profile, based on publicly available information

Joy Aifuobhokhan

Lakeshore Cancer Centre, Lagos, Nigeria

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2025 in International Journal of Advances in Artificial Intelligence and Machine Learning
Verified
Journal Article
Open access
PDF file
JAJoy Aifuobhokhan
Joy Aifuobhokhan
AHAhmad Khalid Hussain
Ahmad Khalid Hussain
CEChijioke Cyriacus Ekechi
Chijioke Cyriacus Ekechi
AOAisha Olasunbo Olanrewaju
Aisha Olasunbo Olanrewaju
EAEmmanuel Afuadajo
Emmanuel Afuadajo
OIOluwadare Marvellous Inioluwa
Oluwadare Marvellous Inioluwa
Background of study: Differentiated thyroid cancer (DTC) accounts for most thyroid malignancies and has favorable survival outcomes, yet up to 30% of patients experience recurrence, placing strain on follow-up systems in resource-limited settings. Conventional staging tools offer limited predictive precision. With increasing interest in machine learning (ML) for precision oncology, there is a need for interpretable, deployable models suitable for low-resource environments.Aims and scope of paper: To develop and validate an interpretable machine learning model for predicting thyroid cancer recurrence and assess its feasibility for deployment in constrained clinical settings, including African oncology contexts.Methods: A retrospective dataset of 383 DTC patients with at least 10-year follow-up was sourced from the UCI Machine Learning Repository. Thirteen demographic, clinical, and treatment-related predictors were included. Data preprocessing involved encoding, scaling, and class balancing using SMOTE. Logistic Regression, Random Forest, K-Nearest Neighbors, and Extreme Gradient Boosting (XGBoost) were trained with hyperparameter tuning via grid search and cross-validation. Performance was evaluated using accuracy, precision, recall, F1 score, and AUC-ROC.Result: XGBoost achieved the best performance with 97% accuracy, 95% recall, 94% precision, and an AUC-ROC of 0.93. The most influential predictors were age, smoking status, T and M staging, ATA risk category, and adenopathy. The final model was deployed as a browser-based decision support tool to enable real-time recurrence risk estimation.Conclusion: This study presents a high-performing and interpretable ML model for predicting DTC recurrence, demonstrating feasibility for use in low-resource oncology settings. External validation with African clinical datasets and integration into electronic health systems is recommended to enhance equity and clinical uptake.

30 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
JAJoy Aifuobhokhan
Joy Aifuobhokhan
AOAyodeji Ogunjinmi
Ayodeji Ogunjinmi
CAChukwuemeka Abraham Agbarakwe
Chukwuemeka Abraham Agbarakwe
DODeborah Oladunmolu Oduguwa
Deborah Oladunmolu Oduguwa
AEAnnie Peter Essiet
Annie Peter Essiet
AMAkinbogun Modesire
Akinbogun Modesire
Background Maternal mortality remains disproportionately high in low- and middle-income countries, particularly in rural settings with limited access to skilled obstetric care. Artificial intelligence and machine learning models offer promise for early risk prediction, yet their methodological rigor, applicability, and deployment feasibility in resource-constrained rural contexts remain inadequately synthesized. This systematic review evaluated AI-powered risk prediction models for preventable maternal mortality, emphasizing suitability for rural and low-resource settings. Methods A systematic literature search was conducted across PubMed, Scopus, Web of Science, IEEE Xplore, Google Scholar, and African Journals Online for studies published January 2015 to August 2025. Studies employing AI or machine learning to predict maternal mortality or severe maternal outcomes were included. The Prediction model Risk Of Bias Assessment Tool (PROBAST) assessed methodological quality across four domains: participants, predictors, outcomes, and analysis. Data extraction captured study characteristics, model architectures, performance metrics, validation strategies, and rural implementation considerations. This review was registered with PROSPERO (CRD420251174343) and reported per PRISMA 2020 guidelines. Results Twenty-eight studies met inclusion criteria, predominantly from sub-Saharan Africa (n = 12) and South Asia (n = 8). Dataset sizes ranged from 402 to over 31 million records from national surveys (n = 14), hospital registries (n = 9), and Internet of Things monitoring systems (n = 5). Random Forest (n = 14), ensemble methods (n = 11), and neural networks (n = 11) were most frequently employed. Reported area under the receiver operating characteristic curve values ranged from 0.70 to 0.95 (median 0.84), with sensitivity 70–92% and specificity 65–85%. PROBAST assessment revealed low risk of bias for participants (24/28), predictors (25/28), and outcomes (24/28), but substantial concerns in the analysis domain (14/28 low risk, 8/28 high risk). Key limitations included reliance on synthetic oversampling without external validation, inadequate calibration reporting, and small sample sizes in IoT studies. Only 11 studies (39%) conducted external validation. Common predictors were maternal age, blood pressure, gestational age, parity, and antenatal care attendance. Rural implementation barriers included limited connectivity, data sparsity, workforce training needs, and the absence of explainability frameworks. Conclusions AI-powered models demonstrate strong discrimination performance for maternal mortality prediction when trained on large, representative datasets. However, methodological weaknesses, particularly inadequate external validation and calibration assessment, limit generalizability confidence. Underrepresentation of rural populations and scarcity of implementation studies constrain real-world applicability. Future development should prioritize federated learning for privacy-preserving multi-site collaboration, lightweight architectures for offline deployment, explainable AI frameworks, and integration into community health worker workflows to achieve equitable, scalable solutions for reducing preventable maternal deaths in rural low- and middle-income country settings. Systematic review registration: PROSPERO CRD42025174343

24 July 2026 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
JAJoy Aifuobhokhan
Joy Aifuobhokhan
AOAyodeji Ogunjinmi
Ayodeji Ogunjinmi
CAChukwuemeka Abraham Agbarakwe
Chukwuemeka Abraham Agbarakwe
DODeborah Oladunmolu Oduguwa
Deborah Oladunmolu Oduguwa
AEAnnie Peter Essiet
Annie Peter Essiet
AMAkinbogun Modesire
Akinbogun Modesire
Maternal mortality remains disproportionately high in low- and middle-income countries, particularly in rural settings with limited access to skilled obste